Theriva Biologics, Inc.
TOVX
$0.25
$0.014.52%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 44.11% | 12.46% | -54.12% | -26.96% | -45.16% |
| Total Receivables | 5.31% | 15.41% | -8.89% | -2.64% | -11.11% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.40% | -41.46% | -27.79% | -28.91% | -38.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -77.46% | -78.30% |
| Total Current Assets | 34.31% | 7.28% | -49.30% | -25.22% | -42.39% |
|
|
|||||
| Total Current Assets | 34.31% | 7.28% | -49.30% | -25.22% | -42.39% |
| Net Property, Plant & Equipment | 50.28% | -33.53% | -31.63% | -28.03% | -29.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.97% | 12.65% | 4.83% | 2.05% | -6.32% |
| Total Assets | 18.93% | 8.17% | -23.12% | -15.48% | -34.00% |
|
|
|||||
| Total Accounts Payable | 39.13% | 18.04% | 5.16% | -35.08% | -23.47% |
| Total Accrued Expenses | 50.06% | 48.91% | 67.14% | 119.29% | 8.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.95% | 1.00% | 11.39% | 16.17% | 10.54% |
| Total Finance Division Other Current Liabilities | -5.24% | 3.78% | 20.20% | 52.61% | 212.53% |
| Total Other Current Liabilities | -5.24% | 3.78% | 20.20% | 52.61% | 212.53% |
| Total Current Liabilities | 25.97% | 32.02% | 50.25% | 80.99% | 35.60% |
|
|
|||||
| Total Current Liabilities | 25.97% | 32.02% | 50.25% | 80.99% | 35.60% |
| Long-Term Debt | 8.11% | 1,716.30% | 1,587.76% | 1,662.37% | 845.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 107.92% | -59.68% | -58.16% | -49.74% | -43.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 50.27% | 39.87% | 56.88% | 59.46% | -12.04% |
| Total Liabilities | 37.12% | 40.35% | 55.74% | 70.96% | 14.08% |
|
|
|||||
| Common Stock & APIC | 5.75% | 5.10% | 2.15% | 3.65% | 2.57% |
| Retained Earnings | -6.32% | -7.09% | -7.92% | -9.16% | -7.89% |
| Treasury Stock & Other | 110.96% | 131.86% | 369.89% | 150.65% | 1.58% |
| Total Common Equity | -0.63% | -19.32% | -72.65% | -58.98% | -50.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.63% | -19.32% | -72.65% | -58.98% | -50.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.63% | -19.32% | -72.65% | -61.57% | -54.58% |
|
|
|||||